Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jared Gollob currently holds 159,299 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jared Gollob has been a net seller of KYMR stock. They have purchased $0 and sold $19.5M worth of shares.
Jared Gollob's most recent insider trade was on Dec 8, 2025, when they sold 49,307 shares at $5.33 per share.
Jared Gollob serves as Executive at Kymera Therapeutics, Inc. (KYMR). They have executed 61 insider transactions totaling $19.5M over their tenure at the company.
Jared Gollob holds the position of Executive at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Jared Gollob has shown a selling trading pattern, with $0 in total purchases and $19.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jared Gollob was on Oct 15, 2025, when they sold $1.8M worth of KYMR shares. This transaction involved 29,264 shares at $60.37 per share.
Jared Gollob currently owns 159,299 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jared Gollob's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jared Gollob has 61 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Jared Gollob and 40,000+ other insiders.